The store will not work correctly when cookies are disabled.
Trimethyl-[4-(4-methyl-2-oxo-pyrrolidin-1-yl)-but-2-ynyl]-ammonium iodide
ID: ALA119508
Chembl Id: CHEMBL119508
PubChem CID: 14964512
Max Phase: Preclinical
Molecular Formula: C12H21IN2O
Molecular Weight: 209.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: C[C@@H]1CC(=O)N(CC#CC[N+](C)(C)C)C1.[I-]
Standard InChI: InChI=1S/C12H21N2O.HI/c1-11-9-12(15)13(10-11)7-5-6-8-14(2,3)4;/h11H,7-10H2,1-4H3;1H/q+1;/p-1/t11-;/m1./s1
Standard InChI Key: LWCMIKHZQAGDAM-RFVHGSKJSA-M
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 209.31 | Molecular Weight (Monoisotopic): 209.1648 | AlogP: 0.56 | #Rotatable Bonds: 2 |
Polar Surface Area: 20.31 | Molecular Species: NEUTRAL | HBA: 1 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: -3.66 | CX LogD: -3.66 |
Aromatic Rings: ┄ | Heavy Atoms: 15 | QED Weighted: 0.48 | Np Likeness Score: 0.07 |
References
1. Trybulski EJ, Zhang J, Kramss RH, Mangano RM.. (1993) The synthesis and biochemical pharmacology of enantiomerically pure methylated oxotremorine derivatives., 36 (23): [PMID:8246221] [10.1021/jm00075a007] |